The Indian Council of Medical Research (ICMR) has given its nod to Rajasthan's appeal for using convalescent plasma therapy in treating COVID-19 patients, Chief Minister Ashok Gehlot said on Sunday.
He said the state government has made all preparations for using plasma therapy on coronavirus patients in critical condition as per the protocol set by the country's apex health research body.
"This will be performed in a proper manner in Rajasthan," the chief minister said.
Gehlot said that doctors from SMS Medical College are also conducting plasma therapy research which is being conducted round the globe.
Under convalescent plasma therapy technique, plasma from people who have recovered from COVID-19 is transfused to patients who are in severe condition.
The centre has, however, said plasma therapy for treatment of coronavirus patients is at an experimental stage and it has the potential to cause life-threatening complication.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
